Enoxaparin‐induced bullous hemorrhagic dermatosis at a distant location from the injection site
Abstract Heparin‐induced bullous hemorrhagic dermatosis is a benign and self‐limited condition. However, it might cause significant patient frustration. Clinicians should be aware of this rare adverse reaction.
Saved in:
Main Authors: | Abdulrahman F. Al‐Mashdali, Mohamed A. Yassin |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d22a5bbfc9694b13bf46d4ac5fb985b7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
by: Murray R, et al.
Published: (2021) -
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
by: Pieter M.M. De Kesel, et al.
Published: (2020) -
Hiponatremia e hiperpotasemia persistente inducida por enoxaparina y revertida con hidrocortisona en paciente con metástasis lumbares
by: Eymin,Gonzalo
Published: (2021) -
Terra firma-forme dermatosis: A report of ten individuals with Duncan’s dirty dermatosis and literature review
by: Tanya Greywal, et al.
Published: (2015) -
Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications
by: Tahaineh L, et al.
Published: (2018)